InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+99.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sandler Laura Lee, Chief Operating Officer. Director active across 1 company, notably Oruka Therapeutics, Inc.. In total, 2 reports have been logged. History available since 2 January 2026. The latest transaction was filed on 2 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations2 total
5,000 shares@ US$7.8050.0% of flowCommon StockSEC:0000907654-26-000002
5,000 shares@ US$7.800.0009% mcap50.0% of flowCommon StockSEC:0000907654-26-000002:0
2 of 2 declarations
About Sandler Laura Lee
Laura Lee Sandler is the Chief Operating Officer at Oruka Therapeutics, Inc. She oversees the daily operations of the company, ensuring efficiency and resource optimization. Her role is essential in achieving Oruka's strategic objectives.
